Clinical Trial: A Study Assessing KB407 for the Treatment of Cystic Fibrosis
Study Status: Completed
Recruit Status: RECRUITING
Condition: Cystic Fibrosis
Study Type: INTERVENTIONAL
Official Title: KB407-02 A Phase 1 Study of Inhaled KB407, a Replication-Defective, Non-Integrating Vector Expressing Human Cystic Fibrosis Transmembrane Conductance Regulator, for the Treatment of Cystic Fibrosis
Brief Summary:
This study will evaluate safety and tolerability of ascending doses of nebulized KB407 in adults with cystic fibrosis.
Read more